<?xml version="1.0" encoding="UTF-8"?>
<p id="p0020">A number of antiviral drugs are either proposed or are in the clinical experimental phase, to test their safety and efficacies, by administrating one or more of these drugs to patients suffering from Covid-19. These are Chloroquine phosphate and hydroxychloroquine sulphate (also known as anti-malarial drugs), arbidol, Remdesivir (GS-5734), Favipitavir and ribavirin (a complex structure but best viewed as ribosyl purine analogues). So far, some promising results have been seen 
 <xref rid="b0010" ref-type="bibr">[3]</xref>, 
 <xref rid="b0015" ref-type="bibr">[4]</xref>, 
 <xref rid="b0020" ref-type="bibr">[5]</xref> yet none of these antiviral drugs for managing coronavirus infection in humans has yet been approved by the relevant Drug Regulatory Authorities.
</p>
